ArticleEClinicalMedicine2024

Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial.

Paolo Mulatero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.